Virtual Screening and Molecular Dynamics Simulation Targeting the ATP Domain of African Swine Fever Virus Type II DNA Topoisomerase
Viruses · 2025
DOI: 10.3390/v17050681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Rui Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China. Hauptthemen laut MEDLINE: African Swine Fever Virus, Molecular Dynamics Simulation, Adenosine Triphosphate, DNA Topoisomerases, Type II. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central public-interest Scientific Institution Basal Research Fund, Innovation Program of Chinese Academy of Agricultural Sciences, the National Key Research and Development Program of China.
Abstract (Originalsprache)
African Swine Fever Virus (ASFV) Topo II ATPase domain, resistant to conventional inhibitors (e.g., ICRF-187) due to M18/W19 steric clashes, was targeted via hierarchical virtual screening (Schrödinger) of the Chembridge library combined with MM/GBSA calculations. Five ligands (10012949, 40242484, 46712145, 15880207, and 33688815) showed high affinity, with 46712145 adopting symmetrical π–π stacking, hydrogen bonds, and alkyl interactions to bypass steric hindrance. Molecular dynamics simulations (100 ns) revealed ligand-induced flexibility, evidenced by elevated RMSD/Rg values versus the free protein. DCCM analysis highlighted enhanced anti-correlated motions between GHKL motifs and sensor domains in chain B/C, suggesting stabilization of a non-catalytic conformation to inhibit ATP hydrolysis. Free energy landscape (FEL) analysis showed 46712145 occupying a broad, shallow energy basin, enabling conformational adaptability, contrasting the narrow deep well of the free protein. This study proposes a symmetric ligand design strategy and conformational capture mechanism to block ATPase activity. Compound 46712145 demonstrates stable binding and dynamic regulation, providing a novel lead scaffold for anti-ASFV drug development. These findings establish a structural framework for combating ASFV through targeted ATPase inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China.
- State Key Laboratory for Animal Disease Control and Prevention, National African Swine Fever Para-Reference Laboratory, National High Containment Facilities for Animal Diseases Control and Prevention, Harbin Veterinary…
- College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.
ORCID-Profile: Weldu Tesfagaber, Dongming Zhao
Förderung
- Central public-interest Scientific Institution Basal Research Fund
- Innovation Program of Chinese Academy of Agricultural Sciences
- the National Key Research and Development Program of China
- the Heilongjiang Provincial Natural Science Foundation of China
- National Key Research and Development Program of China
- Heilongjiang Provincial Natural Science Foundation of China
Zitieren
APA
Zhao, R., Hou, L., Tesfagaber, W., Song, L., Zhang, Z., Li, F., Bu, Z., & Zhao, D. (2025). Virtual Screening and Molecular Dynamics Simulation Targeting the ATP Domain of African Swine Fever Virus Type II DNA Topoisomerase. Viruses. https://doi.org/10.3390/v17050681
Vancouver
Zhao R, Hou L, Tesfagaber W, Song L, Zhang Z, Li F, et al. Virtual Screening and Molecular Dynamics Simulation Targeting the ATP Domain of African Swine Fever Virus Type II DNA Topoisomerase. Viruses. 2025. doi:10.3390/v17050681
BibTeX
@article{Zhao2025,
author = {Zhao, Rui and Hou, Lezi and Tesfagaber, Weldu and Song, Linfei and Zhang, Zhenjiang and Li, Fang and Bu, Zhigao and Zhao, Dongming},
title = {Virtual Screening and Molecular Dynamics Simulation Targeting the ATP Domain of African Swine Fever Virus Type II DNA Topoisomerase},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050681}
}
EUVIMED